Tesetaxel
From Infogalactic: the planetary knowledge core
(Redirected from DJ-927)
![]() |
|
Systematic (IUPAC) name | |
---|---|
(2aS,2bR,3S,4S,6S,8aR,10S,11aS,11bR,13aR)-2a-(acetyloxy)-6-{[(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-(3-fluoropyridin-2-yl)-2-hydroxypropanoyl]oxy}-10-[(dimethylamino)methyl]-4-hydroxy-7,11b,14,14-tetramethyl-2a,2b,3,4,5,6,8a,11a,11b,12,13,13a-dodecahydro-2H-4,8-methano[1,3]dioxolo[3,4]cyclodeca[1,2-d][1]benzoxet-3-yl benzoate
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 333754-36-2 ![]() |
ATC code | none |
PubChem | CID: 6918574 |
UNII | UG97LO5M8Y ![]() |
Chemical data | |
Formula | C46H60FN3O13 |
Molecular mass | 881.98 g/mol |
|
|
|
|
![]() ![]() |
Tesetaxel (DJ-927) is a drug being investigated for chemotherapy of various types of cancer, including breast cancer,[1] gastric cancer,[2] and other solid tumours.[3]
References
- ↑ Clinical trial number NCT01609127 for "Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer" at ClinicalTrials.gov
- ↑ Clinical trial number NCT01348009 for "Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer" at ClinicalTrials.gov
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Mitotic inhibitors
- Benzoates
- Carbamates
- Pyridines
- Organofluorides
- Alcohols
- Ketones
- Acetate esters
- Taxanes
- Antineoplastic and immunomodulating drug stubs